103 related articles for article (PubMed ID: 25756203)
1. Familial risks and estrogen receptor-positive breast cancer in Hong Kong Chinese women.
Tse LA; Li M; Chan WC; Kwok CH; Leung SL; Wu C; Yu IT; Yu WC; Lao X; Wang X; Wong CK; Lee PM; Wang F; Yang XR
PLoS One; 2015; 10(3):e0120741. PubMed ID: 25756203
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of breast cancer risk associated with tea consumption by menopausal and estrogen receptor status among Chinese women in Hong Kong.
Li M; Tse LA; Chan WC; Kwok CH; Leung SL; Wu C; Yu WC; Yu IT; Yu CH; Wang F; Sung H; Yang XR
Cancer Epidemiol; 2016 Feb; 40():73-8. PubMed ID: 26680603
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
[TBL] [Abstract][Full Text] [Related]
4. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.
Han S; Lee KM; Choi JY; Park SK; Lee JY; Lee JE; Noh DY; Ahn SH; Han W; Kim DH; Hong YC; Ha E; Yoo KY; Kang D
Breast Cancer Res Treat; 2008 Jul; 110(2):387-93. PubMed ID: 17940865
[TBL] [Abstract][Full Text] [Related]
5. Reproductive and hormonal factors, family history, and breast cancer according to the hormonal receptor status.
Rosato V; Bosetti C; Negri E; Talamini R; Dal Maso L; Malvezzi M; Falcini F; Montella M; La Vecchia C
Eur J Cancer Prev; 2014 Sep; 23(5):412-7. PubMed ID: 23817433
[TBL] [Abstract][Full Text] [Related]
6. A case-control study of lifetime light intensity physical activity and breast cancer risk.
Kobayashi LC; Janssen I; Richardson H; Lai AS; Spinelli JJ; Aronson KJ
Cancer Causes Control; 2014 Jan; 25(1):133-40. PubMed ID: 24158779
[TBL] [Abstract][Full Text] [Related]
7. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.
Nichols HB; Trentham-Dietz A; Love RR; Hampton JM; Hoang Anh PT; Allred DC; Mohsin SK; Newcomb PA
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):41-7. PubMed ID: 15668474
[TBL] [Abstract][Full Text] [Related]
8. Risk of second breast cancer according to estrogen receptor status and family history.
Bouchardy C; Benhamou S; Fioretta G; Verkooijen HM; Chappuis PO; Neyroud-Caspar I; Castiglione M; Vinh-Hung V; Vlastos G; Rapiti E
Breast Cancer Res Treat; 2011 May; 127(1):233-41. PubMed ID: 20878464
[TBL] [Abstract][Full Text] [Related]
9. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status.
Rusiecki JA; Holford TR; Zahm SH; Zheng T
Cancer Detect Prev; 2005; 29(5):419-26. PubMed ID: 16185815
[TBL] [Abstract][Full Text] [Related]
11. Alcohol and breast cancer risk defined by estrogen and progesterone receptor status: a case-control study.
Deandrea S; Talamini R; Foschi R; Montella M; Dal Maso L; Falcini F; La Vecchia C; Franceschi S; Negri E
Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2025-8. PubMed ID: 18708394
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor positive operable breast cancer: does menopausal status impact on HER2 and progesterone receptor status?
Wang N; Wang B; Wang Y; Hu J
Breast; 2011 Dec; 20(6):519-24. PubMed ID: 21700456
[TBL] [Abstract][Full Text] [Related]
14. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women.
Zeleniuch-Jacquotte A; Toniolo P; Levitz M; Shore RE; Koenig KL; Banerjee S; Strax P; Pasternack BS
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):857-60. PubMed ID: 8634657
[TBL] [Abstract][Full Text] [Related]
15. Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status.
Zhang M; Yang H; Holman CD
Breast Cancer Res Treat; 2009 Dec; 118(3):553-63. PubMed ID: 19252980
[TBL] [Abstract][Full Text] [Related]
16. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
17. Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer.
Touillaud MS; Pillow PC; Jakovljevic J; Bondy ML; Singletary SE; Li D; Chang S
Nutr Cancer; 2005; 51(2):162-9. PubMed ID: 15860438
[TBL] [Abstract][Full Text] [Related]
18. Association between chronological change of reproductive factors and breast cancer risk defined by hormone receptor status: results from the Seoul Breast Cancer Study.
Chung S; Park SK; Sung H; Song N; Han W; Noh DY; Ahn SH; Yoo KY; Choi JY; Kang D
Breast Cancer Res Treat; 2013 Aug; 140(3):557-65. PubMed ID: 23901017
[TBL] [Abstract][Full Text] [Related]
19. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.
Sung H; Lee KM; Choi JY; Han S; Lee JY; Li L; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
Breast Cancer Res Treat; 2011 Dec; 130(3):939-51. PubMed ID: 21766210
[TBL] [Abstract][Full Text] [Related]
20. Body weight correlates with mortality in early-stage breast cancer.
Enger SM; Greif JM; Polikoff J; Press M
Arch Surg; 2004 Sep; 139(9):954-58; discussion 958-60. PubMed ID: 15381612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
